Price target
30.000.000.00%
The 6 analysts offering 1 year price forecasts for CUV have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to CUV in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CUV EPS for the last quarter is 0.49 AUD despite the estimation of 0.44 AUD. In the next quarter EPS is expected to reach 0.21 AUD. Track more of CLINUVEL PHARMACEUTICALS LIMITED financials and stay on top of what is up with the company.
In the next quarter CLINUVEL PHARMACEUTICALS LIMITED revenue is expected to reach 34.65 M AUD. Check out CLINUVEL PHARMACEUTICALS LIMITED revenue and earnings and make informed decisions.
According to analysts, CUV price target is 30.00 AUD with a max estimate of 48.00 AUD and a min estimate of 17.00 AUD. Check if this forecast comes true in a year, meanwhile watch CLINUVEL PHARMACEUTICALS LIMITED stock price chart and keep track of the current situation with CUV news and stock market news.
We've gathered opinions of 7 analysts rating CUV stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.